Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Catalent Maryland Inc
EIR
•Catalent Maryland Inc•November 17, 2021

Catalent Maryland Inc – FDA EIR, Nov 17, 2021

Record Details

An FDA inspection of Catalent Maryland Inc. was conducted from November 8-17, 2021, under the regulatory framework of CP 7345.848 for Biological Drug Products (CBER), focusing on Somatic Cell and Gene Therapy manufacturing as a full Good Manufacturing Practice (GMP) inspection. The inspection was specifically prompted by a significant cross-contamination event involving a licensed gene therapy product with another gene therapy manufactured at the facility. At the conclusion, a seven-item Form FDA 483 was issued, highlighting several critical deficiencies. Main issues included the manufacturing of a product outside validated ranges, inadequate procedures for introducing new products to prevent facility or product contamination, and insufficient quality oversight for investigating errors. Further observations noted deficient procedures for sample analysis, shortcomings in the environmental monitoring system within classified processing areas, incomplete investigations, and inadequate storage space for materials and laboratory samples. Management confirmed their intention to provide a written response to the FDA 483, outlining their required corrective actions to address these serious compliance concerns.

Company
Catalent Maryland Inc
Inspection date
November 17, 2021
Product type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Gowri Manickam (company_representative)
  • Chad Atwell (company_representative)
  • Michael McGlynn (company_representative)
  • Dan Marsteller (company_representative)
  • Christopher Baker (company_representative)
View Company Profile

ID · 03bb4edc-783b-4f67-85cd-78c9ab7171f4

Violation Codes1
21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Catalent Maryland Inc
  • 483 - 2025-04-28April 28, 2025
  • EIR - 2023-03-10March 10, 2023
  • 483 - 2023-03-10March 10, 2023
  • 483 - 2021-11-17November 17, 2021
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Maryland Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.